Physician profile
Michael Newnam
NPI 1851355812
$284,390.34
in general payments reported to CMS, 2019-2025
18 companies · $51K in 2025
The $51K reported for 2025 was more than what 97% of Sleep Medicine (Family Medicine) providers received nationally (typical 2025 total: $557).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49K · 2020: $28K · 2021: $38K · 2022: $36K · 2023: $55K · 2024: $28K · 2025: $51K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $103K · Travel and Lodging: $13K · Consulting Fee: $10K · Food and Beverage: $6,734 · Education: $540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $102,740.00 |
| Travel and Lodging | $13,136.62 |
| Consulting Fee | $10,195.00 |
| Food and Beverage | $6,734.20 |
| Education | $539.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $218,880.24 | 2019-2025 | Xywav |
| Idorsia Pharmaceuticals US INC | $27,386.74 | 2022-2024 | Quviviq |
| Harmony Biosciences LLC | $24,653.67 | 2020-2025 | Wakix |
| Axsome Therapeutics, INC. | $10,430.30 | 2023 | Sunosi |
| Inspire Medical Systems, INC. | $1,872.23 | 2023-2025 | Inspire |
| Fisher & Paykel Healthcare INC | $373.55 | 2021-2025 | Fisher & Paykel Healthcare |
| Zoll Respicardia, INC. | $233.57 | 2023-2025 | Remede System |
| Itamar Medical INC | $144.75 | 2023-2024 | Watchpatone |
| Avadel Cns Pharmaceuticals, LLC | $141.60 | 2023-2025 | Lumryz |
| Lilly USA, LLC | $123.29 | 2025 | Zepbound |
| Philips North America LLC | $27.38 | 2025 | Dreamwear |
| Eisai INC. | $26.14 | 2021 | |
| Amarin Pharma, INC. | $20.65 | 2019 | |
| Arbor Pharmaceuticals, INC. | $19.38 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.28 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.62 | 2019 | |
| Apria Healthcare LLC | $13.02 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Newnam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.